Plinabulin | Interleukin Related interleukin-related.com

Product Name :
Plinabulin

Search keywords :
Factor H

drugId :
null

Target Vo:
Rho guanine nucleotide exchange factor 2

Target Vo Short Name :
GEF-H1

Moa_Name:
Rho guanine nucleotide exchange factor 2 agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Nereus Pharmaceuticals Inc

Active Company_Name :
BeyondSpring Pharmaceuticals Inc

Active Indication_Name:
Neutropenia

In Active Indication_Name:
Chemotherapy-Induced Febrile Neutropenia

Termination Status :

China Termination Status :

Highest Status:
NDA/BLA

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
DNMT1 Mouse mAb Autophagy
S100A10 (Y10P93) Mouse mAb manufacturer
DDIT3 Antibody: DDIT3 Antibody is an unconjugated, approximately 19 kDa, rabbit-derived, anti-DDIT3 polyclonal antibody. DDIT3 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit, sheep background without labeling.

Author: Interleukin Related

Related Posts